MKI67 and neoplasm: A study conducted in Japan that looked at the prognostic value of KI-67 found that patients over 65 years of age develop tumors with a lower proliferation rate; there was no difference in the KI-67 tumor index for patients aged 36–50 and 50–65 years [8].